EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integration of multi‐omics layers empowers precision diagnosis through unveiling pathogenic mechanisms on maple syrup urine disease

Juan Ramón Tejedor, Alejandro Soriano-Sexto iD, Leonardo Beccari, Natalia Castejón-Fernández, Patricia Correcher, Lidia Sainz-Ledo, Juan José Alba-Linares, Rocío G Urdinguio, Magdalena Ugarte, Agustín F Fernández, Pilar Rodríguez-Pombo, Mario F Fraga und 1 weitere

Journal of Inherited Metabolic Disease · 2025

DOI: 10.1002/jimd.12829 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Juan Ramón Tejedor und 12 weiteren Autor:innen. Beteiligte Einrichtung: Nanomaterials and Nanotechnology Research Centre (CINN-CSIC), Spanish National Research Council (CSIC), Principality of Asturias, Spain. Hauptthemen laut MEDLINE: Maple Syrup Urine Disease, DNA Methylation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health Research Institute Carlos III (ISCIII), European Regional Development Fund, Asturias Government, Plan de Ciencia Tecnología e Innovación (PCTI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maple syrup urine disease (MSUD) is a rare inherited metabolic disorder characterized by deficient activity of the branched‐chain alpha‐ketoacid dehydrogenase (BCKDH) complex, required to metabolize the amino acids leucine, isoleucine, and valine. Despite its profound metabolic implications, the molecular alterations underlying this metabolic impairment had not yet been completely elucidated. We performed a comprehensive multi‐omics integration analysis, including genomic, epigenomic, and transcriptomic data from fibroblasts derived from a cohort of MSUD patients and unaffected controls to genetically characterize an MSUD case and to unravel the MSUD pathophysiology. MSUD patients exhibit a defined episignature that reshapes the global DNA methylation landscape, resulting in the stimulation of HOX cluster genes and the restriction of cell cycle gene‐related signatures. Subsequent data integration revealed the impact of AP1‐related and CEBPB transcription factors on the observed molecular reorganization, with MEIS1 emerging as a potential downstream candidate affected by robust epigenetic repression in MSUD patients. Furthermore, the integration of multi‐omics layers facilitated the identification of a strong epigenetic repression in the DBT promoter in a patient wherein no BCKDH pathogenic variants had been detected. A Circular Chromatin Conformation Capture assay indicated a disturbance of the interactions of DBT promoter, thereby unveiling alternative modes of disease inheritance. Integration of multi‐omics data unveiled underlying molecular networks rewired in MSUD patients and represents a powerful approach with diagnostic potential for rare genetic disorders with unknown genetic bases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Maple Syrup Urine DiseaseDNA MethylationHumansEpigenesis, GeneticMaleFibroblastsMyeloid Ecotropic Viral Integration Site 1 ProteinCCAAT-Enhancer-Binding Protein-beta3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)FemalePrecision MedicinePromoter Regions, GeneticEpigenomicsGenomicsMultiomics

Stichwörter der Autor:innen

data integrationepigenomicsmaple syrup urine diseasemolecular diagnosticstranscriptomics

Substanzen

Myeloid Ecotropic Viral Integration Site 1 ProteinCCAAT-Enhancer-Binding Protein-betaCEBPB protein, human3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)

Autor:innen und Institutionen

  • Nanomaterials and Nanotechnology Research Centre (CINN-CSIC), Spanish National Research Council (CSIC), Principality of Asturias, Spain.
  • Health Research Institute of Asturias (ISPA), Foundation for Biomedical Research and Innovation in Asturias (FINBA), Principality of Asturias, Spain.
  • University Institute of Oncology of Asturias (IUOPA), Principality of Asturias, Spain.
  • Centre for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain.
  • Molecular Disease Diagnostic Center (CEDEM), Department of Molecular Biology, Autonomous University of Madrid (UAM), Madrid, Spain.
  • Centre for Molecular Biology (CBMSO), Spanish National Research Council (CSIC), Madrid, Spain.

ORCID-Profile: Alejandro Soriano-Sexto, Belén Pérez

Förderung

  • Health Research Institute Carlos III (ISCIII)
  • European Regional Development Fund
  • Asturias Government, Plan de Ciencia Tecnología e Innovación (PCTI)
  • Ministerio de Ciencia, Innovación y Universidades
  • Instituto de Salud Carlos III

Zitieren

APA

Tejedor, J. R., Soriano-Sexto, A., Beccari, L., Castejón-Fernández, N., Correcher, P., Sainz-Ledo, L., Alba-Linares, J. J., Urdinguio, R. G., Ugarte, M., Fernández, A. F., Rodríguez-Pombo, P., Fraga, M. F., & Pérez, B. (2025). Integration of multi‐omics layers empowers precision diagnosis through unveiling pathogenic mechanisms on maple syrup urine disease. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12829

Vancouver

Tejedor JR, Soriano-Sexto A, Beccari L, Castejón-Fernández N, Correcher P, Sainz-Ledo L, et al. Integration of multi‐omics layers empowers precision diagnosis through unveiling pathogenic mechanisms on maple syrup urine disease. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.12829

BibTeX
@article{Tejedor2025,
  author = {Tejedor, Juan Ramón and Soriano-Sexto, Alejandro and Beccari, Leonardo and Castejón-Fernández, Natalia and Correcher, Patricia and Sainz-Ledo, Lidia and Alba-Linares, Juan José and Urdinguio, Rocío G and Ugarte, Magdalena and Fernández, Agustín F and Rodríguez-Pombo, Pilar and Fraga, Mario F and Pérez, Belén},
  title = {Integration of multi‐omics layers empowers precision diagnosis through unveiling pathogenic mechanisms on maple syrup urine disease},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  doi = {10.1002/jimd.12829}
}
Kostenlos starten →